Wells Fargo & Company Absci Corp Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Absci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 90,622 shares of ABSI stock, worth $259,178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,622
Previous 66,881
35.5%
Holding current value
$259,178
Previous $171,000
60.82%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ABSI
# of Institutions
154Shares Held
70.2MCall Options Held
701KPut Options Held
541K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.2MShares$34.8 Million0.26% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$23.6 Million2.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.28MShares$20.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$15.3 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.19MShares$9.13 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $266M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....